Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Total Liabilities (2020 - 2025)

Definitive Healthcare (DH) has disclosed Total Liabilities for 6 consecutive years, with $356.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities fell 26.07% year-over-year to $356.5 million, compared with a TTM value of $356.5 million through Dec 2025, down 26.07%, and an annual FY2025 reading of $356.5 million, down 26.07% over the prior year.
  • Total Liabilities was $356.5 million for Q4 2025 at Definitive Healthcare, down from $365.9 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $653.0 million in Q1 2023 and bottomed at $356.5 million in Q4 2025.
  • Average Total Liabilities over 5 years is $551.2 million, with a median of $603.3 million recorded in 2021.
  • The sharpest move saw Total Liabilities increased 16.6% in 2022, then tumbled 39.4% in 2025.
  • Year by year, Total Liabilities stood at $617.8 million in 2021, then rose by 3.71% to $640.7 million in 2022, then decreased by 2.18% to $626.7 million in 2023, then fell by 23.06% to $482.2 million in 2024, then decreased by 26.07% to $356.5 million in 2025.
  • Business Quant data shows Total Liabilities for DH at $356.5 million in Q4 2025, $365.9 million in Q3 2025, and $358.9 million in Q2 2025.